← Back to Search

Iron Supplement

FeraMAX for Iron-Deficiency Anemia

N/A
Waitlist Available
Research Sponsored by Dr. Anil K. Gupta Medicine Professional Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks from baseline
Awards & highlights

Study Summary

This trial aims to compare different types of iron supplements to see which ones are more effective and better tolerated for treating iron deficiency anemia. The study will focus on the cost and tolerability of the supplements

Who is the study for?
This trial is for adults aged 18 or older who are dealing with iron deficiency anemia. Participants should have a confirmed diagnosis of IDA and be willing to take oral iron supplements. Specific details about what might exclude someone from participating aren't provided, but typically these criteria would involve health conditions that could interfere with the study or risk participant safety.Check my eligibility
What is being tested?
The trial is testing three different types of iron supplements: Ferrous Ascorbate (EBMfer), Ferrous Fumarate (Eurofer), and Polysaccharide Iron (FeraMax). It aims to find out which one raises hemoglobin levels best over a period of three months, considering both effectiveness and tolerability.See study design
What are the potential side effects?
Common side effects of oral iron supplements can include stomach upset, constipation, diarrhea, nausea, and dark stools. The severity can vary among individuals and different formulations may reduce some side effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Hemoglobin Levels
Secondary outcome measures
Change in Serum Ferritin
Tolerability of Study Medication - Discontinuation Rate

Trial Design

3Treatment groups
Active Control
Group I: FeraMAXActive Control1 Intervention
Polysaccharide Iron - 150mg
Group II: EuroferActive Control1 Intervention
Ferrous Fumarate - 300 mg
Group III: EBMferActive Control1 Intervention
Ferrous Ascorbate - 100 mg

Find a Location

Who is running the clinical trial?

Dr. Anil K. Gupta Medicine Professional CorporationLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still available openings for new participants in this research study?

"As per the details on clinicaltrials.gov, recruitment for this particular study is closed. The trial was initially listed on 2/24/2024 and most recently revised on 3/8/2024. However, there are currently 272 alternative trials actively seeking participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years
2024. "Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06303531.
~74 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top